FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2025/02/080170 [Registered on: 10/02/2025] Trial Registered Prospectively
Last Modified On: 07/02/2025
Post Graduate Thesis  Yes 
Type of Trial  Observational 
Type of Study   Cross Sectional Study 
Study Design  Single Arm Study 
Public Title of Study   To search for microscopic infection causing bacteria in urine and relate it with mutrakrucchra- An Ayurveda terminology related to urine infection 
Scientific Title of Study   Identification and categorization of pathogens in doshaja mutrakrucchra vis-a-vis urinary tract infections 
Trial Acronym  Nil 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Sannuthi Chandana Sri 
Designation  PG Scholar 
Affiliation  Jss Ayurveda Medical College  
Address  Jss Ayurveda Medical College 41/E Lalithadripura road Myusuru

Mysore
KARNATAKA
570028
India 
Phone  9502030912  
Fax    
Email  chandanasannuthi@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Madhusudan B G  
Designation  Associate professor  
Affiliation  JSS Ayurveda Medical College  
Address  JSS Ayurveda Medical College 41/E Lalithadripura road Mysuru

Mysore
KARNATAKA
570028
India 
Phone  9986284748  
Fax    
Email  drmadhusudanbg@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr Sannuthi Chandana Sri 
Designation  PG Scholar 
Affiliation  Jss Ayurveda Medical College 
Address  Jss Ayurveda Medical College 41/E Lalithadripura road Myusuru

Mysore
KARNATAKA
570028
India 
Phone  9502030912  
Fax    
Email  chandanasannuthi@gmail.com  
 
Source of Monetary or Material Support  
JSS Ayurveda Medical Hospital Lalithadripura road Mysuru-570028 Karnataka India 
 
Primary Sponsor  
Name  Dr Sannuthi Chandana Sri 
Address  JSS AYURVEDA MEDICAL COLLEGE 41/E lalithadripura road Mysuru, karnataka 570028 
Type of Sponsor  Other [SELF] 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Sannuthi Chandana Sri  Jss Ayurveda Medical Hospital   Dept of Roga Nidan evam Vikriti Vigyan 41/E Lalithadripura road Mysuru 570028
Mysore
KARNATAKA 
9502030912

chandanasannuthi@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institutional Ethical Clearance Committee - Human  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition:N390||Urinary tract infection, site notspecified. Ayurveda Condition: MUTRAKRUCCRAM,  
 
Intervention / Comparator Agent  
snoIntervention/ComparatorTypeDrug-TypeProcedure NameDetails
 
Inclusion Criteria  
Age From  5.00 Year(s)
Age To  70.00 Year(s)
Gender  Both 
Details  Subjects willing to participate in this study
Subjects fulfilling diagnostic criteria
Subjects of both the genders of all age groups 
 
ExclusionCriteria 
Details  Subjects with Sannipataja,Sharkaraja,Ashmarija,Shukraja,Kshataja, Shakrut Mutrakrucchra
Subjects with positive HIV,HbsAg
Sample of catheter associated urinary tract infections 
 
Method of Generating Random Sequence    
Method of Concealment    
Blinding/Masking    
Primary Outcome  
Outcome  TimePoints 
Classification of Doshaja Mutrakrucchra based on causative organism  Day 1 
 
Secondary Outcome  
Outcome  TimePoints 
Nil  Nil 
 
Target Sample Size   Total Sample Size="40"
Sample Size from India="40" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   N/A 
Date of First Enrollment (India)   20/02/2025 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  20/02/2025 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="6"
Days="0" 
Recruitment Status of Trial (Global)   Not Yet Recruiting 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary     Mutrakrucchra is a disease characterized by difficulty in voiding of urine.  This is classified into 8 types – Vataja, Pittaja, Kaphaja, Sannipataja, Ashmarija, Kshataja, Shukraja and Sharkaraja. The clinical features are similar to that of urinary tract infections caused by microbes. 
UTI is commonly caused by Escherichia coli, Staphylococcus saprophyticus, Staphylococcus aureus, Enterococcus species, Klebsiella pneumoniae, Citrobacter species, Proteus species, Acinetobacter, Morganella species, Pseudomonas aeruginosa and Yeast 
The prevalence of UTI in women is greater than men. In women 3% of prevalence and increasing by about 1% in each subsequent decade. Whereas after the age of 50 years, UTI occurrence is also more in male and also in the age group <1year There is no direct reference mentioned in Samhita that Mutrakrucchra is caused by Krimi. Whereas, based on the similarity in the clinical features, we can understand that UTI is similar to that of Mutrakrucchra. Therefore, we can infer that Mutrakrucchra can be caused due to Krimi also. The causative organisms of the UTI are the inhabitants of colon and blood 9, from this we can infer that if Purishaja Krimi or Raktaja Krimi enters Mutravaha Srotas, it causes Mutrakrucchra. Hence, this study intends to identify the microorganisms responsible for causation of Mutrakrucchra and categorize them among Doshaja Mutrakrucchra. Thus, this will be a first of its kind study to bridge the Ayurveda classical knowledge to modern microbiology understanding to characterize microorganisms causing different types of Mutrakrucchra, which can be a torch bearer for future clinical approach in cases of Mutrakrucchra.
 
Close